By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Exonate Limited 

Cambridge Science Park, Unit 23
Milton Road
Cambridge    CB4 0EY  United Kingdom
Phone: 0115-823-1135 Fax: n/a


SEARCH JOBS

Exonate Limited was founded in 2013 and is based in Nottingham and Cambridge in the UK. Exonate is a biopharmaceutical company focussed on the discovery and development of small molecule drugs that modulate alternative mRNA splicing to address diseases of high unmet medical need. Alternative mRNA splicing is modulated in disease states resulting in pathological blood vessel formation (angiogenesis), which is a key driver of disease progression in ophthalmic conditions and cancer Exonate’s founders have identified and generated a novel class of drugs, “SPHINXes,” that modulate alternative mRNA splicing. We have developed a pipeline of molecules that promise therapeutics for anti-angiogenic therapies in ophthalmology, oncology, analgesia, diabetes, neurodegeneration and renal disease.

YEAR FOUNDED:

2013

LEADERSHIP:

CEO: Dr. Catherine Beech MB ChB OBE

CSO: Professor David Bates

Medical Director: Professor Steven J. Harper

Founding Scientist: Dr. Lucy Donaldson

CAREER:

Please click here for Exonate's job opportunities.

TECHNOLOGY:

Please click here for Exonate's technology.


Key Statistics


Email:
Ownership: Private

Web Site: Exonate
Employees:
Symbol: 
 









Company News
//-->